BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 10967703)

  • 21. [Riluzole as a treatment for amyotrophic lateral sclerosis].
    Borrás-Blasco J; Plaza-Macías I; Navarro-Ruiz A; Perís-Martí J; Antón-Cano A
    Rev Neurol; 1998 Dec; 27(160):1021-7. PubMed ID: 9951030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [What are the etiological medical therapies in amyotrophic lateral sclerosis?].
    Dib M
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS.
    Ajroud-Driss S; Saeed M; Khan H; Siddique N; Hung WY; Sufit R; Heller S; Armstrong J; Casey P; Siddique T; Lukas TJ
    Amyotroph Lateral Scler; 2007 Oct; 8(5):305-9. PubMed ID: 17852022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of sporadic amyotrophic lateral sclerosis treated with non-invasive ventilation and riluzole.
    Sívori M; Rodríguez GE; Pascansky D; Sáenz C; Sica RE
    Medicina (B Aires); 2007; 67(4):326-30. PubMed ID: 17891927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Riluzole-induced recurrent pancreatitis.
    Falcão de Campos C; de Carvalho M
    J Clin Neurosci; 2017 Nov; 45():153-154. PubMed ID: 28867362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ALS/MND prevalence in Sweden estimated by riluzole sales statistics.
    Nygren I; Antonova K; Mattsson P; Askmark H
    Acta Neurol Scand; 2005 Mar; 111(3):180-4. PubMed ID: 15691287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minocycline in amyotrophic lateral sclerosis: a pilot study.
    Pontieri FE; Ricci A; Pellicano C; Benincasa D; Buttarelli FR
    Neurol Sci; 2005 Oct; 26(4):285-7. PubMed ID: 16193258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS.
    Scelsa SN; MacGowan DJ; Mitsumoto H; Imperato T; LeValley AJ; Liu MH; DelBene M; Kim MY
    Neurology; 2005 Apr; 64(7):1298-300. PubMed ID: 15824372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward more efficient clinical trials for amyotrophic lateral sclerosis.
    Cudkowicz ME; Katz J; Moore DH; O'Neill G; Glass JD; Mitsumoto H; Appel S; Ravina B; Kieburtz K; Shoulson I; Kaufmann P; Khan J; Simpson E; Shefner J; Levin B; Cwik V; Schoenfeld D; Aggarwal S; McDermott MP; Miller RG
    Amyotroph Lateral Scler; 2010 May; 11(3):259-65. PubMed ID: 19961263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cotreatment of amyotrophic lateral sclerosis patients].
    Iwasaki Y; Ikeda K
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1253-5. PubMed ID: 10791091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Riluzole in Huntington's disease: a 3-year, randomized controlled study.
    Landwehrmeyer GB; Dubois B; de Yébenes JG; Kremer B; Gaus W; Kraus PH; Przuntek H; Dib M; Doble A; Fischer W; Ludolph AC;
    Ann Neurol; 2007 Sep; 62(3):262-72. PubMed ID: 17702031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease-modifying drug therapies.
    Brooks BR; Sanjak M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():68-75. PubMed ID: 15512878
    [No Abstract]   [Full Text] [Related]  

  • 33. Population pharmacokinetics of riluzole in patients with amyotrophic lateral sclerosis.
    Bruno R; Vivier N; Montay G; Le Liboux A; Powe LK; Delumeau JC; Rhodes GR
    Clin Pharmacol Ther; 1997 Nov; 62(5):518-26. PubMed ID: 9390108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS.
    Limousin N; Blasco H; Corcia P; Gordon PH; De Toffol B; Andres C; Praline J
    J Neurol Sci; 2010 Oct; 297(1-2):36-9. PubMed ID: 20673675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measures of quality of life: pro.
    Ludolph AC
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S19. PubMed ID: 12396796
    [No Abstract]   [Full Text] [Related]  

  • 36. [The advance in the research and therapeutic trials of amyotrophic lateral sclerosis].
    Moriwaka F; Tashiro K
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1258-60. PubMed ID: 11464472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2007 Jan; (1):CD001447. PubMed ID: 17253460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interest of a computerized ALS database in the diagnosis and follow-up of patients with ALS].
    Couratier P; Druet-Cabanac M; Truong CT; Bernet-Bernady P; Dumas M; Vallat JM; Preux PM
    Rev Neurol (Paris); 2000 Apr; 156(4):357-63. PubMed ID: 10795012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug therapy for amyotrophic lateral sclerosis: Where are we now?
    Carter GT; Krivickas LS; Weydt P; Weiss MD; Miller RG
    IDrugs; 2003 Feb; 6(2):147-53. PubMed ID: 12789618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three soccer playing friends with simultaneous amyotrophic lateral sclerosis.
    Wicks P; Ganesalingham J; Collin C; Prevett M; Leigh NP; Al-Chalabi A
    Amyotroph Lateral Scler; 2007 Jun; 8(3):177-9. PubMed ID: 17538780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.